WebSep 6, 2024 · Usual Dosing (Adults) Dosing and AdministrationFor patients who do not have HIT/HITTS PCI/PTCA: 0.75 mg/kg intravenous (IV) bolus dose followed by a … WebOct 17, 2024 · The aPTT declined 11% during PIRRT session 1, but began to rise after dialysis ended and bivalirudin was adjusted to 0.11 mg/kg/h. The patient remained within the therapeutic range for the next 48 h undergoing 2 additional PIRRT sessions. During the second and third PIRRT sessions, aPTTs transiently declined by 24% and 6%, …
Bivalirudin - GlobalRPH
WebNov 16, 2005 · Bivalirudin was initiated by continuous intravenous infusion (range 0.03–0.2 mg/kg/h) and adjusted to an aPTT of 1.5–2.5 times patient baseline. The mean infusion rate was 0.1 mg/kg/h. The average duration of therapy was 7.8 (range 1–24) days. 7/42 (16.7%) of patients had overt bleeding and received ≥ 2 units of packed red blood cells ... WebApr 11, 2024 · In the United States, about one million people are seen to visit the operating theater for cardiac surgery annually. However, nearly half of these visits result in complications such as renal, neurological, and cardiac injury of varying degrees. Historically, many mechanisms and approaches have been explored in attempts to reduce injuries … share house living
The use of bivalirudin in patients with renal impairment
WebJan 20, 2024 · 1 INDICATIONS AND USAGE Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia ... 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage - Bivalirudin for Injection is for … WebThe disposition of bivalirudin was studied in PTCA patients with mild and moderate renal function and in patients with severe renal function. Drug elimination was related to glomerular filtration rate (GFR). Total body clearance was similar for patients with normal renal function and with mild renal impairment (60-89mL/min). Clearance WebSep 15, 2024 · Bivalirudin is a prescription medicine used to treat the symptoms of Percutaneous Coronary Intervention. Bivalirudin may be used alone or with other medications. Bivalirudin belongs to a class of drugs called Anticoagulants, Cardiovascular; Anticoagulants, Hematologic. It is not known if Bivalirudin is safe and effective in children. sharehouse logo